Join to View Full Profile
5 E 98th StFirst floorNew York, NY 10029
Phone+1 212-241-7958
Fax+1 212-241-4460
Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Aaron Miller, MD, is a neurologist based in New York, NY, with a subspecialty in neuroimmunology and multiple sclerosis. He completed his neurology residency at Montefiore Medical Center/Albert Einstein College of Medicine after attending New York University School of Medicine. Dr. Miller's expertise includes multiple sclerosis, headache disorders, and neuroimmunology. His recent publications focus on multiple sclerosis treatments and their effects, and some have been cited by other scholarly articles. He has also been involved in numerous clinical trials evaluating treatments for MS. He has been consistently listed among New York Magazine's Best Doctors and among America's Best Physicians.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 1973 - 1975- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 1970 - 1971
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1968 - 1970
New York University School of MedicineClass of 1968
Certifications & Licensure
NY State Medical License 1969 - 2026
NJ State Medical License 2021 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- MS Hope Award National MS Society--Greater New York Long Island Chapter, 2021
Clinical Trials
- Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS Relapses Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- Cognitive effects of ocrelizumab vs interferon β-1a in relapsing multiple sclerosis: A post hoc analysis of the OPERA I/II trials.Ralph Hb Benedict, Ludwig Kappos, Aaron Miller, Hans-Peter Hartung, James Overell
Multiple Sclerosis and Related Disorders. 2025-03-01 - DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial.John R Corboy, Robert J Fox, Gary Cutter, Eric Engebretson, Aaron Miller
Multiple Sclerosis. 2025-02-01 - 3 citationsDissemination in time as a requirement for diagnosis of multiple sclerosis: Time for a change?Aaron E Miller
Multiple Sclerosis. 2024-04-01
Press Mentions
Mount Sinai MS Experts Earn Hope AwardSeptember 24th, 2021- Two Mount Sinai Experts Receive Honors from the National Multiple Sclerosis SocietySeptember 16th, 2021
First Relapsing MS Patient Enrolled in Phase 3 Trial of Mapi Pharma’s Once-Monthly Glatiramer FormulationOctober 30th, 2019- Join now to see all
Professional Memberships
- Fellow
- American Neurological AssociationFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
